AbCellera Receives Authorization From Health Canada To Initiate The Phase 1 Clinical Trial Of Abcl635 For Vasomotor Symptoms Due To Menopause

Published: 2025-05-14 17:03:08 ET ABCL

Published on 05/14/2025 at 17:03